Procter & Gamble Health Limited Sustainability Profile
Procter & Gamble Health Limited, a subsidiary of the renowned Procter & Gamble Company, is headquartered in India and operates extensively across the Indian subcontinent. Established in 2015, the company has quickly positioned itself within the health and wellness industry, focusing on innovative consumer health products. P&G Health Limited offers a diverse range of products, including over-the-counter medications, dietary supplements, and personal care items, all designed to enhance everyday health. Their commitment to quality and efficacy sets them apart in a competitive market. With a strong emphasis on research and development, Procter & Gamble Health Limited has achieved significant milestones, contributing to its reputation as a trusted leader in health solutions. The company continues to expand its market presence, driven by a dedication to improving consumer health and well-being.
DitchCarbon Score
How does Procter & Gamble Health Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Procter & Gamble Health Limited's score of 72 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Procter & Gamble Health Limited, headquartered in India, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of The Procter & Gamble Company, which cascades its climate commitments and initiatives down to its subsidiaries. While specific emissions figures are not provided, Procter & Gamble Health Limited adheres to the sustainability and climate strategies set forth by its parent company. The Procter & Gamble Company has established various reduction initiatives, including targets aligned with the Science Based Targets initiative (SBTi), and participates in multiple climate-related initiatives such as CDP, RE100, and Climate Pledge. As a subsidiary, Procter & Gamble Health Limited is expected to align with these overarching commitments, focusing on reducing its carbon footprint and contributing to the parent company's sustainability goals. However, without specific emissions data or reduction targets for Procter & Gamble Health Limited, the details of its individual climate commitments remain vague.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 2,193,927,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 3,210,213,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | 000,000,000,000 | 000,000,000,000 | 000,000,000,000 | 000,000,000,000 | - | - | - | - |
How Carbon Intensive is Procter & Gamble Health Limited's Industry?
How Carbon Intensive is Procter & Gamble Health Limited's Location?
Procter & Gamble Health Limited's Scope 3 Categories Breakdown
Procter & Gamble Health Limited's Scope 3 emissions, which increased by 13% last year and increased by approximately 18% since 2016, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 85% of Scope 3 emissions.
Top Scope 3 Categories
Procter & Gamble Health Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Procter & Gamble Health Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
